AI as a gamechanger in Life Sciences & Health - Part 2
Clinical trials are a crucial step in the development of new drugs, but at the same time, they are among the most complex and costly processes in the pharmaceutical industry. Selecting the right patients, monitoring treatment outcomes, and ensuring safety require significant time and resources. This is where AI emerges as a game changer. By leveraging smart technologies, pharmaceutical companies can better address these challenges, making clinical studies more efficient, safer, and more effective. In this part of the blog, we explore how AI has the potential to fundamentally improve clinical trials, paving the way for faster and better healthcare innovations.
Clinical trials
Identifying the right patients for a clinical trial is a complex and time-consuming process. Additionally, monitoring treatment responses and potential side effects comes with substantial costs. AI technology offers pharmaceutical companies opportunities to tackle these challenges, improving the efficiency and effectiveness of clinical studies. 1,2
- Patient selection: AI can analyze vast datasets, including electronic health records, genetic profiles, and medical histories, to identify subpopulations of patients who are most likely to benefit from a new drug. This not only reduces the inclusion of unsuitable candidates but also increases the likelihood of positive outcomes. Tools such as natural language processing (NLP) can scan medical texts and physician reports to find potential participants.
- Real-time monitoring: AI-driven systems can utilize wearable devices and sensors to continuously monitor participants’ health, allowing for early detection of anomalies or side effects. This contributes to improved patient safety.
- Predicting side effects: AI algorithms can detect patterns in patient data that indicate potential adverse effects—even before they become clinically significant. This enables doctors to take preventive measures, reducing risks for patients and helping to prevent premature termination of clinical trials.
- Efficient data management: Machine learning enables the rapid processing and analysis of large volumes of research data, providing researchers with better insights into the results. An additional advantage is that AI can identify patterns that human researchers might overlook.
In practice: AI in clinical trials
By leveraging AI intelligently, pharmaceutical companies can not only reduce costs and accelerate processes but also contribute to better treatment outcomes and a higher chance of successfully introducing innovative drugs. A great example is how the pharmaceutical company Johnson & Johnson (J&J) has been utilizing AI in clinical research. In a recent interview, Hans Verstraete (Senior Director of Data Science at J&J) stated:
“AI can screen medical images for specific mutations and thus predict more quickly which cancer patients would benefit from participating in a clinical trial. Additionally, across the industry, pharmaceutical companies can conduct clinical trials on average 5–10% faster with the support of AI. This also benefits pharmaceutical companies, as they are the ones funding these clinical trials.”3
The next section of this blog will discuss AI applications in diagnostics.
References
- Mourya A, et al. AI-powered clinical trials and the imperative for regulatory transparency and accountability. Health Technol. 2024;1071–1081.
- Hutson M. How AI is being used to accelerate clinical trials. Nature. 2024;627:S2-S5.
- AI versnelt medicijnontwikkeling, maar is geen wonderpil | De Tijd